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Introduction
Serum-and glucocorticoid-inducible protein kinase 1 (SGK1) is a member of a family of serine/threonine kinases that shares 45-55% homology of the catalytic domain with Akt, cAMP-dependent protein kinase, p70 S6K and protein kinase C [1] . It was originally identified Dulbecco's modified Eagle's medium (DMEM) (Invitrogen) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Hyclone, Logan, UT) and 10% horse serum (Invitrogen) was added to the hippocampi and a single-cell suspension was produced by mechanically dissociating the cells using a Pasteur pipette with a fire-narrowed tip. Cells were plated into poly-L-lysine (Sigma, St. Louis, MO) coated 6-well plates (Costar, Cambridge, MA), at a density of 1 × 10 5 cells/cm 2 , and incubated in the same medium described above overnight at 37°C in 5% CO 2 in air. Next day the cells were changed to serum-free B27/neurobasal medium (Sigma), and maintained for 7 to 10 days, during which half the culture medium was replaced every 3 days.
Immunofluorescence analysis
Protein expression in vitro: at the end of the culture period, neurons were washed in phosphatebuffered saline (PBS), fixed in 4% paraformaldehyde for 1 h, then assessed by immunostaining for the neuronspecific marker microtubule-associated protein-2 (MAP-2) and SGK1. Briefly, fixed cells were blocked for 1 h by incubating with 5% BSA, then incubated with a mouse monoclonal to MAP-2 or rabbit polyclonal to SGK-1 (both from Abcam), diluted at 1:500 in PBS with 1% bovine serum albumin (BSA) overnight at 4°C. After washing three times, the cells were incubated with appropriate secondary antibodies: fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG (1:100) for MAP-2, and rhodamine-conjugated anti-rabbit IgG (1:100) for SGK1. Staining was performed for 1 h in the dark at 37°C. Samples incubated with nonimmune IgG at the same dilution were used as negative controls. Cell nuclei were counterstained with the DNA-specific dye Hoescht 33258 (Sigma) at a final concentration of 5 µg/mL, and specimens were viewed under a Nikon TE2000-S fluorescence microscope (Nikon Inc., Tokyo, Japan).
Protein expression in vivo: Twenty-four hours after reperfusion, rats were anesthetized and perfused with saline, followed by 4% paraformaldehyde, through the ascending aorta. The brains were then removed and post-fixed in 4% paraformaldehyde for 24 h, before changing to 20% sucrose for 2-3 days, then 30% sucrose for a further 2-3 days. Brains were then embedded in OCT compound, and 10 µm frozen sections were cut for immunostaining. To block non-specific staining, sections were incubated for 2 h at room temperature in PBS with 10% non-immune serum, 3% (w/v) bovine serum albumin (BSA), 0.1% Triton X-100 and 0.05% Tween 20. The sections were then incubated overnight at 4ºC with both the antibody against SGK-1 (1:100, Abcam) as above, and a mouse monoclonal antibody against the neuronal marker NeuN (1:1000; Abcam). Next day, sections were washed and incubated for 2 h at 4ºC with a mixture of FITCand TRITC-conjugated secondary antibodies to detect neurons and SGK-1, respectively. Control sections were processed without primary antibody. Cells double-labeled for both SGK-1 and NeuN were counted and expressed as a proportion of the NeuN cells; a minimum of 200 NeuN-positive cells was counted in 2 or 3 adjacent sections per rat [16] .
Plasmids and transfection SGK1 was prepared by amplifying the rat SGK1 mRNA (NM_001193568.1) using the following primers: Forward, 5'-CAAGGAAACGTCAGTGCTCG-3', Reverse, 5'-ACATGGGAAATACGCAAGGGT-3' The polymerase chain reaction (PCR) products were subcloned between KpnI and XbaI sites of the mammalian expression vector pCMV4 (BD Biosciences Clontech, Palo Alto, CA) to produce the construct pCMV4-SGK1. All constructs were confirmed by automated DNA sequencing.
Hippocampal neurons were transfected with the empty vector pCMV4 or pCMV4-SGK1 using Lipofectamine 2000 (Invitrogen). Twenty-four hours after transfection, they were trypsinized and seeded for the various assays.
Ischemia reperfusion cell model
Oxygen and glucose deprivation (OGD) was used as a model of in vivo ischemia conditions [14] . OGD of hippocampal neurons was induced by washing the cells with PBS supplemented with 0.5 mM CaCl 2 and 1 mM MgCl 2 then incubating them in an anaerobic chamber (85% N 2 , 5% H 2 , 10% CO 2 , 35°C; Forma Scientific, Marjetta, OH) for 120 min. Anaerobic conditions in the chamber were monitored using Gaspack aerobic indicator strips (BD Biosciences, San Jose, CA). Aerobic conditions were restored by removing the cells from the anaerobic chamber, providing fresh medium and returning them to the normal incubator where they were allowed to recover for 10, 30 or 60 min. 
Cellular Physiology and Biochemistry
To investigate the effect of the PI3K/Akt/GSK3β pathway on the neuroprotective effect exerted by overexpressing SGK1 in the response to OGD, cultures were treated with the PI3K inhibitor LY294002, which was dissolved in 0.2% dimethyl sulfoxide (DMSO) to a concentration of 10 µM and added to cell cultures for 30 min before subjecting them to OGD.
Flow cytometry analysis
Cell apoptosis was determined by annexin-V/PI double-staining followed by flow cytometric analysis, using an annexin-V-FITC/PI apoptosis detection kit (Sigma). At the end of the culture period, cells were trypsinized, washed twice with cold PBS, then pelleted by centrifugation. The pelleted cells were resuspended in 1 × binding buffer and incubated with staining solution at 4°C for 15 min in the dark, then analyzed using a FACSCalibur flow cytometer (BD Biosciences). Ten thousand cells from each sample were scanned and data were analyzed using CellQuest software (BD Biosciences). Necrosis and apoptosis were determined by PI and annexin V-FITC, respectively.
Middle Cerebral Artery Occlusion (MCAO) and Animal Groups
Male Sprague-Dawley rats weighing 270 to 350 g were obtained from the Experimental Animals Center, Kunming Medical University, and housed in a facility with a 12-h light/dark cycle at a controlled temperature and humidity with free access to food and water.
The rats were anesthetized with 10% chloral hydrate (350 mg/kg, i.p.) and subjected to 2 hours of reversible MCAO, using the intraluminal filament technique [17] [18] [19] [20] , followed by 1, 6, 12, or 24 h of reperfusion. Temporalis temperatures were monitored and maintained at 37ºC ± 0.5ºC using heat lamps and water pads, and a femoral artery catheter was positioned to monitor mean artery blood pressure and arterial blood pH and PaCO 2 . Vessel occlusion and reperfusion was assessed by laser-Doppler flowmetry (Moor Instruments, Oxford, UK). Sham-operated group rats underwent the same surgical procedure without MCAO.
Animals were randomly divided into the following groups for treatment: -sham (n = 8); -ischemia/reperfusion (I/R) groups -rats underwent MCAO for 2 hours followed by 1, 6, 12, or 24 h of reperfusion (four groups, n = 8 for each group); SGK1 group (SGK1, n = 8) rats were treated with 5 μL pCMV4-SGK1 lentivirus plasmid (10 9 transfecting units/mL) via intracerebroventricular (icv) injection 2 weeks before MCAO, and injection of 3% DMSO (10 μL, icv) 15 min before MCAO, then underwent MCAO for 2 h followed by 24 h of reperfusion [21] ; I/R control group (I/R, n = 8): rats were injected with 5 μL pCMV4 lentivirus plasmids (icv) 2 weeks before MCAO, and injection of 3% DMSO (10 μL, icv) 15 min before MCAO, then underwent MCAO for 2 hours followed by 24 h of reperfusion.
LY294002 group (LY, n = 8): rats were injected with 5 μL pCMV4 lentivirus plasmids (icv) 2 weeks before MCAO [22] , and injection of the phosphoinositide 3-kinase inhibitor LY294002 (10 μL, 10 mM, in 3% DMSO, icv) 15 min before MCAO [23] . They were then subjected to MCAO for 2 h followed by 24 h of reperfusion.
SGK1 with LY294002 group (SGK1+LY, n = 8): rats were injected with 5 μL pCMV4-SGK1 lentivirus plasmids (10 9 transducing units/mL, icv) 2 weeks before MCAO, and injection of LY294002 (10 μL, 10 mM, in 3% DMSO, icv) 15 min before MCAO. They were then subjected to MCAO for 2 h followed by 24 h of reperfusion.
For plasmid injection, the rats were anesthetized and placed in a stereotaxic apparatus (David Kopf Instruments, Tujunga, CA) then injected into the right lateral ventricle over a 3-min duration with 5 μL pCMV4-SGK1 lentivirus plasmid, using a Hamilton microsyringe. A stereotaxic instrument was used to guide the needle into position with the coordinates of 0.8 mm posterior to the bregma, 1.5 mm lateral to the midline, and 4.5 mm ventral to the surface of the skull [21] .
At the end of treatment, rats in each group were sacrificed by decapitation, and cortical samples of brain tissue were immediately frozen at -70ºC or fixed in 4% paraformaldehyde for further molecular or histologic analysis.
Evaluation of ischemic infarct area
Twenty-four hours after reperfusion, rats were deeply anesthetized with 10% chloral hydrate (350 mg/kg, i.p.) and sacrificed as described above. The brains were quickly removed, five coronal sections of 2 mm thickness were cut, and sections were stained with 2% 2,3,5-triphenyltetrazolium chloride (TTC) solution for 20 min at 37°C in the dark. Stained sections were photographed, and infarct tissue was identified as unstained areas. The infarct area as a proportion of each hemisphere was measured using an image analysis system [18] .
Western blotting analysis
Cultured cells or tissue samples were homogenized on ice in lysis buffer consisting of 60 mM TrisHCl, 2% sodium dodecyl sulfate (SDS), 10% sucrose, 2 mM phenyl methyl sulfonyl fluoride (PMSF), 1 mM sodium orthovanadate, and 10 µg/mL aprotinin. The lysates were briefly sonicated then centrifuged at 15,000 × g at 4°C for 5 min, and the supernatant was collected. Protein concentration was determined using the Bradford assay (Bio-Rad, Hercules, CA) with BSA as the standard [15] . Samples were prepared by diluting in sample buffer (250 mM Tris-HCl, 4% SDS, 10% glycerol, 2% β-mercaptoethanol and 0.002% bromophenol blue) to give equivalent amounts of protein, then boiling for 5 min. The prepared samples were separated by 10% SDS-PAGE then electroblotted onto a nitrocellulose membrane (Invitrogen). The membrane was blocked for 2 h in 5% skimmed milk powder in Tris-buffered saline containing 0.1% Tween 20 (TBST) at room temperature, then incubated with primary antibodies against SGK1 (1:500); cleavedcaspase 3 (1:500); phospho-Akt (S473) (1:200); Akt (1:500); phospho-GSK3β (Y216) (1:500); GSK3β (1:500); or β-actin (1:1000) (all from Abcam) overnight at 4°C. Next day the membrane was washed three times in TBST, then incubated for 1 h at room temperature with the HRP-conjugated goat anti-rabbit IgG H&L/HRP secondary antibody (Abcam) at 1:2000 [24] . Immunoreactive proteins were detected using an enhanced chemiluminescence detection system (Santa Cruz Biotechnology) and visualized using the Sygene Bio image system (Synoptics Ltd., Cambridge, UK). The β-actin gene was used as the internal standard for quantitative comparison of expression.
Real-time PCR analysis
Total RNA was extracted from cultured cells or from brain cortex tissue samples using Trizol reagent (Life Technologies, Carlsbad, CA) according to the manufacturer's instructions. RNA (2 µg) was reversetranscribed into cDNA using a High-Capacity cDNA synthesis kit (Applied Biosystems, CA) [25] . Quantitative real-time RT-PCR was performed using SYBR Green in a Rotor-Gene 3000 (Corbett Research, Sydney, Australia) using the following primers for SGK1:
Forward, 5'-CTCGCTTCTACGCAGCTGAA-3'; Reverse, 5'-GACGTTGTCCCATTGTGCTC-3' with GAPDH as internal standard for quantitative comparison. GAPDH primers: Forward, 5'-GTCGGTGTGAACGGATTTGG-3'; Reverse, 5'-CCCCATTTGATGTTAGCGGG-3' For relative quantitation of gene expression the comparative Ct (threshold cycle) method was used [26] .
TUNEL staining
At the end of the study period, rats were sacrificed and perfused as described above. The brains were then removed and post-fixed in 4% paraformaldehyde for 24 h, before embedding in paraffin and cutting into coronal sections of 4 µm thickness. TUNEL staining was performed according to the manufacturer's instructions (Roche molecular Biochemicals Inc., Mannheim, Germany). Briefly, sections were pretreated with Proteinase K and 0.3% H 2 O 2 , then incubated with terminal deoxynucleotidyl transferase at 37ºC for 1 h. They were then transferred to peroxidase-conjugated antibody for 30 min, followed by color development with 3' diaminobenzidene (DAB). Cells displaying brown staining within the nucleus were counted as TUNEL positive cells. The number of TUNEL-positive cells was counted in 3 non-overlapping microscopic fields under high-power magnification (200×) by one observer blinded to the group assignment, and results are expressed as percentage of total cells [22] .
Statistical analysis
The data were expressed as mean ± S.E. from three independent experiments and the statistical significance was tested by Student's t test. A P value <0.05 was considered statistically significant. *P < 0.05; **P < 0.01. 
Results

Expression of SGK1 in cultured hippocampal neurons
Rat hippocampal neurons were successfully isolated and cultured. As shown in Fig.  1 , immunofluorescence analysis revealed that SGK1 was localized mainly in the nucleus of neurons. SGK1-positive cells were also stained by the neuronal marker microtubuleassociated protein 2 (MAP2).
OGD causes apoptosis of hippocampal neurons
Hippocampal neurons were subjected to 120 min OGD, followed by 10, 30 or 60 min recovery. Flow cytometric analysis with annexin-V/PI double-staining demonstrated that 
Fig. 2.
Flow cytometric analysis of neuronal apoptosis following ischemia-reperfusion. Hippocampal neurons were subjected to 120 min OGD, and then allowed to recover for 10, 30 or 60 min. Cell apoptosis was determined by flow cytometric analysis with annexin-V/PI double-staining (A-B), while western blotting was used to analyze SGK1 protein levels (C-D). NC, neurons without any treatment; OGD, neurons subjected to 120 min OGD; 10 min (30 min or 60 min), cells were allowed to recover for 10 min (30 min or 60 min) after 120-min ODG. **P < 0.01 vs. NC.
Suppression of apoptosis by SGK1 is mediated by the PI3K/Akt/GSK3β pathway
Hippocampal neurons, either untransfected or transfected for 24 h with an expression vector encoding SGK1, were incubated for 30 min with 10 µM LY294002, which blocks PI3K-dependent phosphorylation and kinase activity of Akt, before being subjected to 120 min OGD, and then allowed to recover for 60 min. Cell apoptosis was determined by flow cytometric analysis with annexin-V/PI double-staining. Pre-incubation with LY294002 significantly increased apoptosis both in untreated cells and in normal cells subjected to OGD then 60 min reperfusion, compared to vehicle (DMSO)-treated cells under the same conditions (Fig 4A, B) . LY294002 pretreatment caused a larger increase in apoptosis in SGK1-overexpressing cells than in corresponding normal overexpressing cells (Fig. 4B) . Protein levels of p-Akt, Akt, p-GSK3β, GSK3β, and activated caspase-3 were analyzed by western blotting (Fig. 4C-F) . Levels of p-Akt were reduced by OGD followed by 60 min reperfusion and this reduction was suppressed by SGK1 overexpression. In all treatment groups p-Akt was reduced by LY294002 preincubation, although the reduction was greater in untreated controls. Protein levels of p-GSK3β showed a similar trend. In contrast, cleaved caspase-3 expression was increased more than 2-fold by OGD followed by 60 min reperfusion, and was suppressed almost to normal levels by SGK1 overexpression. LY294002 preincubation caused a modest, though significant, increase in cleaved caspase-3 expression in all conditions (Fig. 4C, F) .
Ischemia-reperfusion (I/R) induces apoptosis in the intact rat brain, and alters SGK1 expression
Rats were subjected to 2 h of MCAO followed by reperfusion for 1, 6, 12 or 24 h, then TUNEL staining was performed on sections from ischemic penumbral cortex of each group. TUNEL staining was barely observed in the sham-operated brains, while following I/R, the number of TUNEL-positive cells clearly increased with time following reperfusion, reaching more than 6% at 24 h (Fig. 5A) .
Evaluation of both mRNA (Fig. 5B ) and protein ( Fig. 5C ) showed that SGK1 levels increased within 1 h after I/R, peaked between 6 and 12 h, and then declined to below control levels. Double immunohistochemical labeling of cells with SGK1 and NeuN, a neuronal marker, confirmed that SGK1 was expressed in rat neurons, and that this expression increased significantly, to almost double the levels in sham-operated animals, by 6 h after I/R and declined to below control levels after 24 h I/R (Fig. 5D ).
SGK1 exerts a protective effect against apoptosis induced by I/R, and this effect is blocked by LY294002
Rats were injected with 5 μL pCMV4-SGK1 (or pCMV4) lentivirus plasmids 2 weeks before MCAO, and injection of LY294002 (or DMSO) 15 min before MCAO. They then underwent 2 h of MCAO followed by reperfusion for 24 h. TUNEL staining of penumbra cortex was barely detectable in the sham-operated brains, but many TUNEL-stained cells were present in the I/R group (Fig. 6A) . The number of positive cells was markedly reduced by SGK1 transfection, and this protective effect was blocked by LY294002 treatment. Stained cells were counted and expressed as a percentage of the total cells in the ischemic penumbral cortex of each group, and demonstrated a highly significant increase in apoptotic cells with I/R and a significant decrease in this apoptosis with SGK1.
Evaluation of the infarct area by TTC staining revealed large injured areas in rats subjected to I/R, and a significant reduction in infarct area with SGK1 transfection. When these areas were quantified as a proportion of each hemisphere there was clearly a 40% reduction in the injured area with SGK1 transfection. LY294002 treatment alone had no effect on infarct area, and when combined with SGK1 transfection the protective effect of SGK1 was blocked (Fig. 6B) .
Western blotting of tissue lysates showed that I/R induced an increase of more than 3-fold in protein expression of cleaved caspase 3 and almost 2-fold in the pro-apoptotic protein Bax, while it reduced levels of the anti-apoptotic protein Bcl-2 to less than half. All these changes were partially but significantly reversed by SGK1 transfection (Fig. 6C ). In agreement with the observations of infarct area, LY294002 treatment completely blocked the effect of SGK1 on all three indicators (Fig. 6C) . Similarly, I/R reduced levels of phosphoAkt and phospho-GSK3β to 26% and 35%, respectively, of levels in sham controls, but levels were partially restored by SGK1 transfection to 71% and 82%, respectively (Fig. 6D) .
Discussion
Hippocampal neurons are particularly vulnerable to death following periods of ischemia [8] , and this has been shown to occur by apoptosis both in experimental animals [27] [28] [29] [30] and in humans [31, 32] . Neuronal apoptosis is important both in brain development and in response to insult, and is known to be regulated in a complex manner by a network of interacting pathways, of which the PI3K pathway may be one of the most significant [33] . There is a wealth of evidence demonstrating the importance of the PI3K-Akt signaling pathway in mediating survival signals in neuronal cells [34] [35] [36] . The protein kinase SGK, which is related to Akt and also activated by PI3K, has also been reported to be involved in mediating survival signals, acting in other cell types via phosphorylation of the forkhead transcription factor FKHRL1 [37] . It has also been shown to regulate the GSK-3β/β-catenin signaling pathway in neurons [16] .
Glycogen synthase kinase (GSK)-3β was originally identified for its role in energy metabolism, but is now recognized as a multifunctional kinase involved in many different cellular functions including regulation of cell survival under a variety of different conditions [13] . There is evidence that GSK-3β is important in modulating cell responses in the central nervous system [16, 38] . The role of GSK3 activation in the regulation of apoptosis remains controversial however, with some studies showing that it promotes apoptosis [39] while others suggest it has a protective effect [40] .
In this study we isolated rat hippocampal neurons and confirmed that they express SGK1. Using OGD as a model of ischemia reperfusion, we found that apoptosis was greatly increased by OGD as expected, and that it also continued to increase with increasing reperfusion time. Expression of SGK1 followed an inverse profile, decreasing with OGD and continuing to decrease over time.
To investigate whether the reduction in SGK1 is involved in the induction of apoptosis, we used a transfection vector to overexpress SGK1 in our cultured neurons. Overexpression of SGK1 was able to markedly reduce apoptosis induced by OGD, demonstrated both by FACS analysis and by a significant reduction in caspase-3 expression. We then investigated the activation of other protein kinases which reportedly mediate ischemic protection, and found that OGD followed by 60 min reperfusion suppresses phosphorylation of both Akt and GSK-3β while increasing caspase-3 expression. Overexpression of SGK1 was able to at least partially restore activation of Akt and GSK-3β. We used the inhibitor LY294002 to investigate the involvement of the PI3K-Akt signaling pathway in protein phosphorylation and the induction of apoptosis. Our results show that SGK1 suppression of apoptosis in hippocampal neurons is mediated, at least partly, via the PI3K/Akt signaling pathway, and suggest that both Akt and GSK-3β have a protective role in hippocampal neurons exposed to ischemiareperfusion.
To confirm that these results are relevant to the in vivo situation, adult male rats were subjected to MCAO as a model of I/R. When MCAO was followed by reperfusion for between 1 and 24 h, TUNEL staining clearly showed a time-dependent increase in apoptosis following I/R. Over the same time-course, analysis of mRNA and protein expression revealed that SGK1 levels transiently increased before returning to control levels by 24 h, while immunohistochemistry confirmed that the SGK1-positive cells were neurons. These observations suggested that increased SGK1 expression by neurons may occur as a protective response following I/R. We then investigated whether SGK1 does in fact exert a protective effect in vivo. Rats were transfected with the SGK1-expressing plasmid 2 weeks before MCAO and reperfusion. The results showed that the marked increase in apoptosis observed following I/R was markedly reduced by SGK1 transfection. This was reflected in changes in the expression of pro-and anti-apoptotic proteins evaluated by western blotting; altered protein expression patterns induced by I/R were found to be partially reversed by SGK1 transfection. Using TTC staining, we evaluated the effects of I/R on whole rat brains, with or without SGK1 transfection, and confirmed that the large infarct area induced by I/R was significantly reduced by SGK1.
Our in vitro results suggested that the protective effect of SGK1 is mediated, at least partly, via the PI3K/Akt signaling pathway so to test this in vivo we treated the plasmidtransfected rats with LY294002 shortly before MCAO. Similar to the in vitro results, we found that the effect of SGK1 in protecting neurons against apoptosis was blocked by treatment
